Personalized imaging after breast lumpectomy
Part of Cancer, Skin clinical trials.
This study looks at a more personalized way to follow up after breast-conserving surgery (lumpectomy). It may use extra imaging scans to detect any return of cancer early, which could help you feel more secure and get treatment sooner if needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with breast cancer that was confirmed by a biopsy.
- You had surgery to remove just the cancer (lumpectomy), not the whole breast, and the goal was to remove all cancer.
- You finished your main cancer treatment (like radiation, chemo, or hormone therapy) as recommended by your doctors.
- Your doctor says you have a higher than average chance of the cancer coming back, based on things like your age and the type of breast cancer.
- You are able to have regular imaging tests (like mammograms or MRI) to watch for cancer returning.
- You are registered in a national or regional breast cancer registry.
- You can keep up with follow-up visits and tests as required by the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging tool that helps surgeons see cancer margins in real time during a lumpectomy, aiming to reduce the need for a second surgery. It is for women with early-stage breast cancer who are planning a lumpectomy.
This study compares two different ways of giving radiation to the breast after lumpectomy for early-stage breast cancer. It may help determine which approach controls the cancer well while reducing radiation to surrounding healthy tissue.
This study records details about radiation delivered while your surgery is happening for certain early breast cancers or pre-cancers. It may help doctors better understand who benefits most from this “intra-operative” radiation approach.
This trial tests a short, highly targeted radiation plan given in five sessions after lumpectomy for early-stage breast cancer. It may help treat the remaining breast area while aiming to limit exposure to healthy tissue.
This trial tests a scanner that checks removed breast tissue during surgery to help surgeons remove all cancer the first time. If it works, fewer women may need a second operation.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.